Design, validation, and development of novel peptidomimetic therapeutics targeting SARS-CoV-2 replication. | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Funder
SERB India
Principal Investigator
Dr. Arockiasamy Arulandu
Research Location
India
Lead Research Institution
International Centre for Genetic Engineering and Biotechnology (ICGEB) New Delhi
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

New or repurposed antivirals against valid viral targets, viricidal coatings

Publicationslinked via Europe PMC

Last Updated:21 hours ago

View all publications at Europe PMC

Modes of Binding of Small Molecules Dictate the Interruption of RBD-ACE2 Complex of SARS-CoV-2.

Zinc²⁺ ion inhibits SARS-CoV-2 main protease and viral replication in vitro.